Skip to main content
OpenTrials

Clinical trial condition

Gram-Negative Bacterial Infections

Explore clinical trials studying Gram-Negative Bacterial Infections. Study availability and eligibility vary by location and protocol.

1,462 public trials 132 recruiting studies
Refine in advanced search Browse all conditions

Gram-Negative Bacterial Infections trial results

Completed

Mortality Reduction After Oral Azithromycin: Morbidity Study

NCT02048007

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Childhood Mortality, +28 more
Locations
  • UCSF Proctor Foundation San Francisco, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • College of Medicine at the University of Malawi, Blantyre Blantyre, Malawi
  • The Carter Center, Niger Niamey, Niger
View Trial Details
Completed

Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612

NCT00955682

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Helsinki, Finland
  • GSK Investigational Site Jarvenpaa, Finland
View all 14 locations
View Trial Details
Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age

NCT03433482

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +11 more
Locations
  • GSK Investigational Site Salvador, Estado de Bahia, Brazil
  • GSK Investigational Site Natal, Rio Grande do Norte, Brazil
  • GSK Investigational Site Rio de Janeiro, Brazil
  • GSK Investigational Site São Paulo, Brazil
View all 49 locations
View Trial Details
Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers

NCT01485406

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
  • GSK Investigational Site Berchtesgaden, Bavaria, Germany
  • GSK Investigational Site Braunatal, Hesse, Germany
  • GSK Investigational Site Berlin, Germany
View Trial Details
Completed

A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of Age

NCT03652610

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • GSK Investigational Site Blacktown, New South Wales, Australia
  • GSK Investigational Site Kanwal, New South Wales, Australia
  • GSK Investigational Site Gold Coast, Queensland, Australia
  • GSK Investigational Site Sherwood, Queensland, Australia
View all 30 locations
View Trial Details
Completed

Effort to Prevent Nosocomial Pneumonia Caused by Pseudomonas Aeruginosa in Mechanically Ventilated Subjects

NCT02696902

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations
  • Research Site Englewood, Colorado, United States
  • Research Site Gainesville, Florida, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Augusta, Georgia, United States
View all 78 locations
View Trial Details

Related conditions